Stockscreener 앱 받기
4.49
0.90%
0.04
시간 외 거래:
4.49
전일 마감가:
$4.45
열려 있는:
$4.47
하루 거래량:
17,513
Relative Volume:
0.66
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.28%
1개월 성능:
+9.51%
6개월 성능:
-22.18%
1년 성능:
-6.84%
1일 변동 폭
$4.425
$4.5692
1주일 범위
$4.37
$4.57
52주 변동 폭
$3.3801
$6.48
Amplify Seymour Cannabis Etf Stock (CNBS) Company Profile
Amplify Seymour Cannabis Etf 주식(CNBS)의 최신 뉴스
Wealth Alliance Makes New Investment in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) - Defense World
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - LongPort
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed By Invezz - Investing.com Canada
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - Invezz
Here's Why Tilray Brands Has Become a Much Better Buy Than Canopy Growth - The Motley Fool
CNBC’s Tim Seymour takes ‘glass half full’ view of second quarter cannabis earnings - Green Market Report
6 Best-Performing Marijuana ETFs for August 2024 - NerdWallet
Cannabis Investing In The Age Of Legalization With Julian Lin, Tim Seymour And Pablo Zuanic - Seeking Alpha
5 Best Cannabis ETFs to Invest In - Securities.io
Amplify Seymour Cannabis ETF (CNBS-A) QuotePress Release - The Globe and Mail
How to invest in cannabis stocks - CNN Underscored
Cannabis Investing In The Age Of Legalization - Seeking Alpha
Cannabis ETFs are off to a strong September. Will the buzz last? - MSN
Cannabis is a $200B market cap industry, analyst says at SA Investing Summit - MSN
Cannabis is a $200B market cap: Pablo Zuanic (NYSEARCA:MSOS) - Seeking Alpha
Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth - Markets Insider
Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis GrowthCresco Labs ... - Benzinga
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth' - Markets Insider
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth'Amplify Seymour ... - Benzinga
6 Best-Performing Marijuana ETFs for June 2024 - NerdWallet
Could Rescheduling Finally Bring Institutional Investment in to Cannabis? - Business of Cannabis -
Private Advisor Group LLC Has $550000 Holdings in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) - Defense World
Cannabis rally sparks concerns amid moves to mainstream - MSN
How the (CNBS) price action is used to our Advantage - Stock Traders Daily
5 ETF Teardowns: What's Under the Hood? - Yahoo Singapore News
7 Best Marijuana ETFs to Buy in 2024 | Investing | U.S. News - U.S News & World Report Money
Why Cannabis Stocks & ETFs Are Soaring - Yahoo News UK
7 Best Marijuana ETFs to Buy in 2024 - U.S News & World Report Money
Best ETF Areas of Last Week - Yahoo Finance
Marijuana ETF Space Gets Packed - Yahoo Movies Canada
Cannabis ETFs Soar On Reports DEA Plans To Reclassify Marijuana - Forbes
Marijuana stocks rise on cannabis rescheduling (NYSEARCA:MSOS) - Seeking Alpha
Cannabis stocks gain as DEA pressed for marijuana rescheduling - Seeking Alpha
The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail
Cannabis Stocks Shine As Benzinga's Cannabis Capital Conference Unfolds - Benzinga
Cannabis rally sparks concerns amid moves to mainstream - Seeking Alpha
Is Rescheduling a Certainty for Cannabis? ETFs That Surge - Yahoo Finance
Cannabis ETFs Jump on Imminent Rescheduling News - Yahoo Finance
Understanding Cannabis ETFs’ Wacky Divergence - Nasdaq
Cannabis stocks rebound amid DEA's rescheduling review - Seeking Alpha
9 Best Marijuana ETFs to Buy in 2024 - The Motley Fool
Cannabis Stocks: Why Tomorrow Might Be Too Late To Invest And How To Pick The Right Stocks - Benzinga
Marijuana ETFs Rise – and Fall – on Regulatory Hopes - ETF Trends
Cannabis Stocks & ETFs: Can the Recent Surge Continue? - Yahoo Lifestyle Australia
Top Performing ETFs: Cannabis ETFs Lead - Nasdaq
Cannabis ETFs are off to a strong September. Will the buzz last? - CNBC
MJ: The Long Awaited Breakout For Marijuana Stocks Is Here! - TheStreet
Amplify's Christian Magoon on Purchase of ETFMG's ETFs - ETF Trends
Here’s Why These Cannabis ETFs Aren’t Very Good - New Cannabis Ventures
'The Only Thing We Can Do As An Industry Is Learn,' Says Emily Paxhia On Navigating The Cannabis Investment Landscape - Benzinga
VA And DoD Face Criticism From Rep. Blumenauer Over 'Misguided' Denial Of PTSD Treatment With Medical Can - Benzinga
Amplify Seymour Cannabis Etf (CNBS) 재무 분석
Amplify Seymour Cannabis Etf (CNBS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.36%
0.35%
자본화:
|
볼륨(24시간):